First test of TT5 in healthy volunteers and surgical patients
Part of Pain clinical trials.
This is a first-in-human study testing a new medicine (TT5) in healthy people and patients recovering from surgery. It checks how the body handles the drug and whether it is safe to use for pain.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You cannot smoke or use tobacco during the study.
- You must be in good general health with no major medical conditions.
- You cannot have a history of asthma, severe allergies, psychiatric disorders, or kidney disease.
- Women who can get pregnant must use birth control; men must use condoms or other effective contraception.
- You must not have taken any other experimental drug or joined another trial in the last month.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is an early-stage study testing a new investigational drug called IG001119 in people who are in good health. Researchers will give increasing doses to small groups to learn how the drug is processed by the body and to check for any side effects.
This trial uses controlled, short-term pain testing (a “pain study”) to better understand how pain works during and after certain cancer treatments. It may help researchers improve how cancer therapy pain is measured and managed.
This study tests a new drug, SBS-147, in healthy adults to see if it's safe and how the body processes it. It may help find the right dose for future studies in people with certain conditions.
This study tests an experimental medicine called LPH-5 in healthy people to see if it is safe and how the body handles it. If you are generally healthy, you might be able to join.
This first-in-human trial tests a new medicine called GRT7041 in healthy people to see how safe it is and how it works in the body. It helps doctors understand the right dose and any side effects before testing in patients.
This study tests a new experimental drug (HW243040) in healthy volunteers to see if it is safe and how the body handles it. It includes pain testing to measure how the drug works on pain.
Hear when a new Pain trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.